The Sydney Morning Herald |
Shares in Clinuvel, run by Dr Phillippe Wolgen, surged as it moves closer to product launch. Photo: Nicole Emanuel
The Sydney Morning Herald "The positive data bolsters our confidence in the performance of the device and we are confident that it should allow Fantom to get CE mark approval for marketing in Europe in the fourth quarter of calendar 2016 as well as attract M&A interest for the ... |
May 18, 2016 at 02:27AM | marketing - Google News
Shares in Clinuvel, run by Dr Phillippe Wolgen, surged as it moves closer to product launch. Photo: Nicole Emanuel - The Sydney Morning Herald
marketing - Google News
Nenhum comentário:
Postar um comentário